Dependence of the cytostatic effect of adriamycin on drug concenration and exposure time in vitro.
暂无分享,去创建一个
[1] K. Trott,et al. Effect of methotrexate concentration and exposure time on mammalian cell survival in vitro. , 1980, British Journal of Cancer.
[2] S. Garattini,et al. Distribution and antitumor activity of adriamycin given in a high-dose and a repeated low-dose schedule to mice. , 1978, Cancer treatment reports.
[3] S. Carter. Adriamycin-a review. , 1975, Journal of the National Cancer Institute.
[4] R. Benjamin,et al. Adriamycin chemotherapy—efficacy, safety, and pharmacologic basis of an intermittent single high‐dosage schedule , 1974, Cancer.
[5] B. Drewinko,et al. Survival kinetics of cultured human lymphoma cells exposed to adriamycin. , 1973, Cancer research.
[6] H. S. Schwartz,et al. A fluorometric assay for daunomycin and adriamycin in animal tissues. , 1973, Biochemical medicine.
[7] H. H. Lloyd,et al. Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules. , 1970, Cancer chemotherapy reports.
[8] V. Levin,et al. SYMPOSIUM ON THE PRINCIPLES OF RADIATION RESEARCH APPLIED TO ENVIRONMENTAL AGENTS The Concept of Drug Dose for in Vitro Studies with Chemotherapeutic Agentsl , 1978 .
[9] W. Creasey,et al. Clinical effects and pharmacokinetics of different dosage schedules of adriamycin. , 1976, Cancer research.
[10] E. Gerner,et al. Survival and cell kinetics effects of adriamycin on mammalian cells. , 1973, Cancer research.